Acalabrutinib With or Without Obinutuzumab in Treating Patients With Early-Stage Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Clinical trial NCT03516617 · RECRUITING
Trial details
- NCT number
- NCT03516617
- Sponsor
- Mayo Clinic
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-09-10
- Primary completion
- 2027-03-15
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.